Janssen Belgium Investors
Janssen Belgium is a pharmaceutical company that conducts research and development in various therapeutic areas, including oncology, mental illness, neurological disorders, gastrointestinal disorders, fungal infection, and allergies. Founded in 1953 by Dr. Paul Janssen, the company aims to provide better care for patients through innovative research and development methods. Janssen Belgium collaborates with partners in over 150 markets and houses all capacities, from lab to patient, including R&D, production, and the launch of new medicines. The company values partnerships and the infusion of innovation and new technologies to fulfill its mission.
Founded Date:
1953
Headquarters:
Beerse, Antwerpen, Belgium
Industry:
AI Pharma
Investor Type:
Pharma Company